USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
17.98
+0.02 (0.11%)
At close: May 15, 2026, 4:00 PM EDT
18.00
+0.02 (0.11%)
After-hours: May 15, 2026, 7:00 PM EDT

USANA Health Sciences Ratios and Metrics

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
3323556801,0251,0221,963
Market Cap Growth
-37.38%-47.77%-33.64%0.35%-47.94%21.00%
Enterprise Value
183.21264.17575.85695.73733.341,723
Last Close Price
17.9819.4435.6953.6053.20101.20
PE Ratio
37.2333.5216.3016.2414.8217.66
Forward PE
8.3611.1714.3119.8517.0519.17
PEG Ratio
0.701.491.491.491.491.49
PS Ratio
0.360.380.801.111.021.65
PB Ratio
0.610.671.282.062.354.97
P/TBV Ratio
0.610.681.292.092.365.21
P/FCF Ratio
-41.6813.3618.2610.9318.09
P/OCF Ratio
19.9715.9011.1614.529.8316.19
EV/Sales Ratio
0.200.290.670.760.731.45
EV/EBITDA Ratio
2.253.426.506.135.688.95
EV/EBIT Ratio
3.737.068.687.486.8110.12
EV/FCF Ratio
-30.9811.3112.397.8415.88
Debt / Equity Ratio
0.020.020.040.0000
Debt / EBITDA Ratio
0.190.180.260.01--
Debt / FCF Ratio
4.731.640.450.01--
Net Debt / Equity Ratio
-0.27-0.27-0.30-0.66-0.66-0.61
Net Debt / EBITDA Ratio
-1.99-1.87-1.79-2.90-2.23-1.25
Net Debt / FCF Ratio
-50.24-16.93-3.12-5.87-3.08-2.21
Asset Turnover
1.251.241.241.501.701.95
Inventory Turnover
2.092.332.462.752.342.31
Quick Ratio
1.691.451.503.002.211.66
Current Ratio
2.512.242.003.522.672.27
Return on Equity (ROE)
1.55%1.96%7.76%13.69%16.72%27.85%
Return on Assets (ROA)
1.09%1.39%5.29%9.43%11.70%19.07%
Return on Invested Capital (ROIC)
1.44%1.84%8.63%19.66%22.11%36.59%
Return on Capital Employed (ROCE)
5.77%6.12%11.82%19.26%24.75%38.26%
Earnings Yield
2.67%2.98%6.14%6.16%6.75%5.66%
FCF Yield
-2.40%7.48%5.48%9.15%5.53%
Buyback Yield / Dilution
3.67%3.07%0.95%-0.18%5.08%4.30%
Total Shareholder Return
3.67%3.07%0.95%-0.18%5.08%4.30%
Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q